Literature DB >> 20378144

There is an A33-dependent mechanism for the incorporation of B5-GFP into vaccinia virus extracellular enveloped virions.

Winnie M Chan1, Brian M Ward.   

Abstract

Orthopoxviruses produce two, antigenically distinct, infectious virions, intracellular mature virions and extracellular virions (EV). A33 and B5 are found on EV but not on intracellular mature virions. To investigate the function of A33, a recombinant virus that has A33R deleted and expresses B5R-GFP (vB5R-GFP/DeltaA33R) was generated. A comparison of vB5R-GFP/DeltaA33R to an analogous virus (vDeltaA33R) revealed an additional defect in infectious EV production that was not apparent when A33R was present. Characterization of these recombinants revealed that EV produced in the absence of A33 had undetectable levels of B5-GFP. Both recombinants released similar amounts of EV but there were differences in their infectivity. Approximately equal numbers of virions produced by these recombinants were able to bind cells even though EV produced by vB5R-GFP/DeltaA33R do not contain B5. These results suggest that in the absence of A33, the cytoplasmic tail of B5 contributes to its incorporation into the envelope of progeny virions. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20378144      PMCID: PMC2872037          DOI: 10.1016/j.virol.2010.03.017

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  40 in total

1.  Golgi network targeting and plasma membrane internalization signals in vaccinia virus B5R envelope protein.

Authors:  B M Ward; B Moss
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Visualization of intracellular movement of vaccinia virus virions containing a green fluorescent protein-B5R membrane protein chimera.

Authors:  B M Ward; B Moss
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

3.  DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge.

Authors:  J W Hooper; D M Custer; C S Schmaljohn; A L Schmaljohn
Journal:  Virology       Date:  2000-01-20       Impact factor: 3.616

4.  The vaccinia virus B5 protein requires A34 for efficient intracellular trafficking from the endoplasmic reticulum to the site of wrapping and incorporation into progeny virions.

Authors:  Amalia K Earley; Winnie M Chan; Brian M Ward
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

5.  Using fluorescent proteins to study poxvirus morphogenesis.

Authors:  Brian M Ward
Journal:  Methods Mol Biol       Date:  2009

6.  The structure of the poxvirus A33 protein reveals a dimer of unique C-type lectin-like domains.

Authors:  Hua-Poo Su; Kavita Singh; Apostolos G Gittis; David N Garboczi
Journal:  J Virol       Date:  2009-12-23       Impact factor: 5.103

7.  The vaccinia virus A33R protein provides a chaperone function for viral membrane localization and tyrosine phosphorylation of the A36R protein.

Authors:  E J Wolffe; A S Weisberg; B Moss
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

8.  The vaccinia virus A36R protein is a type Ib membrane protein present on intracellular but not extracellular enveloped virus particles.

Authors:  H van Eijl; M Hollinshead; G L Smith
Journal:  Virology       Date:  2000-05-25       Impact factor: 3.616

9.  Acidic residues in the membrane-proximal stalk region of vaccinia virus protein B5 are required for glycosaminoglycan-mediated disruption of the extracellular enveloped virus outer membrane.

Authors:  Kim L Roberts; Adrien Breiman; Gemma C Carter; Helen A Ewles; Michael Hollinshead; Mansun Law; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2009-03-04       Impact factor: 3.891

10.  Vaccinia virus utilizes microtubules for movement to the cell surface.

Authors:  M Hollinshead; G Rodger; H Van Eijl; M Law; R Hollinshead; D J Vaux; G L Smith
Journal:  J Cell Biol       Date:  2001-07-23       Impact factor: 10.539

View more
  13 in total

1.  Increased interaction between vaccinia virus proteins A33 and B5 is detrimental to infectious extracellular enveloped virion production.

Authors:  Winnie M Chan; Brian M Ward
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

2.  The A33-dependent incorporation of B5 into extracellular enveloped vaccinia virions is mediated through an interaction between their lumenal domains.

Authors:  Winnie M Chan; Brian M Ward
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

3.  The Ectodomain of the Vaccinia Virus Glycoprotein A34 Is Required for Cell Binding by Extracellular Virions and Contains a Large Region Capable of Interaction with Glycoprotein B5.

Authors:  Stephanie R Monticelli; Amalia K Earley; Jessica Tate; Brian M Ward
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

4.  Modulation of the myxoma virus plaque phenotype by vaccinia virus protein F11.

Authors:  Chad R Irwin; David H Evans
Journal:  J Virol       Date:  2012-04-18       Impact factor: 5.103

5.  The inability of vaccinia virus A33R protein to form intermolecular disulfide-bonded homodimers does not affect the production of infectious extracellular virus.

Authors:  Winnie M Chan; Aja E Kalkanoglu; Brian M Ward
Journal:  Virology       Date:  2010-10-13       Impact factor: 3.616

6.  Vaccinia Virus Phospholipase Protein F13 Promotes Rapid Entry of Extracellular Virions into Cells.

Authors:  Peter Bryk; Matthew G Brewer; Brian M Ward
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

7.  Interaction of poxvirus intracellular mature virion proteins with the TPR domain of kinesin light chain in live infected cells revealed by two-photon-induced fluorescence resonance energy transfer fluorescence lifetime imaging microscopy.

Authors:  Ananya Jeshtadi; Pierre Burgos; Christopher D Stubbs; Anthony W Parker; Linda A King; Michael A Skinner; Stanley W Botchway
Journal:  J Virol       Date:  2010-10-13       Impact factor: 5.103

8.  The Molluscum Contagiosum Gene MC021L Partially Compensates for the Loss of Its Vaccinia Virus Homolog, F13L.

Authors:  Stephanie R Monticelli; Peter Bryk; Brian M Ward
Journal:  J Virol       Date:  2020-09-29       Impact factor: 5.103

9.  Structural and Functional Characterization of Anti-A33 Antibodies Reveal a Potent Cross-Species Orthopoxviruses Neutralizer.

Authors:  Michael H Matho; Andrew Schlossman; Xiangzhi Meng; Mohammed Rafii-El-Idrissi Benhnia; Thomas Kaever; Mark Buller; Konstantin Doronin; Scott Parker; Bjoern Peters; Shane Crotty; Yan Xiang; Dirk M Zajonc
Journal:  PLoS Pathog       Date:  2015-09-01       Impact factor: 6.823

10.  Transport and stability of the vaccinia virus A34 protein is affected by the A33 protein.

Authors:  Adrien Breiman; David C J Carpentier; Helen A Ewles; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2012-12-19       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.